NO951718D0 - Fremgangsmåter og sammensetninger av (+)doksazosin for behandling av godartet hyperplasi og aterosklerose - Google Patents

Fremgangsmåter og sammensetninger av (+)doksazosin for behandling av godartet hyperplasi og aterosklerose

Info

Publication number
NO951718D0
NO951718D0 NO951718A NO951718A NO951718D0 NO 951718 D0 NO951718 D0 NO 951718D0 NO 951718 A NO951718 A NO 951718A NO 951718 A NO951718 A NO 951718A NO 951718 D0 NO951718 D0 NO 951718D0
Authority
NO
Norway
Prior art keywords
doxazosin
atherosclerosis
compositions
treatment
methods
Prior art date
Application number
NO951718A
Other languages
English (en)
Other versions
NO951718L (no
NO308196B1 (no
Inventor
Nancy M Gray
Original Assignee
Sepracor Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sepracor Inc filed Critical Sepracor Inc
Publication of NO951718L publication Critical patent/NO951718L/no
Publication of NO951718D0 publication Critical patent/NO951718D0/no
Publication of NO308196B1 publication Critical patent/NO308196B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
NO951718A 1992-11-04 1995-05-03 Anvendelse av (+)doksazosin for fremstilling av et medikament for behandling av godartet prostatisk hyperplasi for Õ øke urinstrømmen NO308196B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US97068592A 1992-11-04 1992-11-04
PCT/US1993/010503 WO1994009785A2 (en) 1992-11-04 1993-11-02 Methods and compositions of (+) doxazosin for the treatment of benign prostatic hyperplasia and atherosclerosis

Publications (3)

Publication Number Publication Date
NO951718L NO951718L (no) 1995-05-03
NO951718D0 true NO951718D0 (no) 1995-05-03
NO308196B1 NO308196B1 (no) 2000-08-14

Family

ID=25517324

Family Applications (1)

Application Number Title Priority Date Filing Date
NO951718A NO308196B1 (no) 1992-11-04 1995-05-03 Anvendelse av (+)doksazosin for fremstilling av et medikament for behandling av godartet prostatisk hyperplasi for Õ øke urinstrømmen

Country Status (11)

Country Link
US (1) US5508279A (no)
EP (1) EP0667775A1 (no)
JP (1) JPH08502977A (no)
KR (1) KR950703961A (no)
AU (1) AU5546194A (no)
CA (1) CA2147866A1 (no)
HU (1) HU219482B (no)
NO (1) NO308196B1 (no)
NZ (1) NZ257993A (no)
RU (1) RU2139053C1 (no)
WO (1) WO1994009785A2 (no)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL120302A0 (en) * 1996-03-27 1997-06-10 Pfizer Use of alpha1-adrenoreceptor antagonists in the prevention and treatment of benign prostatic hyperplasia
US6177430B1 (en) 1997-03-27 2001-01-23 Pfizer Inc Use of α1-adrenoreceptor antagonists in the prevention and treatment of benign prostatic hyperplasia
US6200573B1 (en) 1999-12-03 2001-03-13 Starcor Pharmaceuticals, Inc. Method of medical management for lower urinary tract symptoms and benign prostatic hyperplasia
IL141235A (en) * 2000-02-09 2012-04-30 Novartis Int Pharm Ltd Combined use of an alpha-adrenoceptor antagonist and a muscarinic antagonist in the preparation of a drug for the treatment of non-malignant prostatic hyperplasia
US6596686B2 (en) 2001-03-12 2003-07-22 International Flavors & Fragrances Inc. Use of dihydropyrans as fragrance Material
DE20220415U1 (de) * 2001-11-07 2003-10-09 Synthon Bv Tamsulosin-Tabletten
US7175127B2 (en) * 2002-09-27 2007-02-13 C.G. Bretting Manufacturing Company, Inc. Rewinder apparatus and method
KR20050092519A (ko) * 2004-03-16 2005-09-22 화이자 인코포레이티드 아토르바스타틴 및 α1-아드레날린성 수용체 길항제의 조합
KR100635301B1 (ko) * 2004-09-15 2006-10-17 지엘팜텍 주식회사 메실산 독사조신을 함유하는 서방성 정제
CN1769285B (zh) * 2004-11-05 2010-05-05 华北制药集团新药研究开发有限责任公司 光学活性的多沙唑嗪盐
CN102321078B (zh) * 2005-11-11 2013-08-28 华北制药集团新药研究开发有限责任公司 (-)多沙唑嗪甲磺酸盐iii型结晶、其制备方法及用途
CN107951852A (zh) * 2017-12-31 2018-04-24 威海贯标信息科技有限公司 一种多沙唑嗪片组合物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4188390A (en) * 1977-11-05 1980-02-12 Pfizer Inc. Antihypertensive 4-amino-2-[4-(1,4-benzodioxan-2-carbonyl) piperazin-1-yl or homopiperazin-1-yl]quinazolines
US5212176A (en) * 1990-06-29 1993-05-18 Abbott Laboratories R(+)-terazosin
IL101243A (en) * 1991-03-20 1999-12-22 Merck & Co Inc Pharmaceutical preparations for the treatment of benign prostatic hyperplasia containing steroid history

Also Published As

Publication number Publication date
HUT73678A (en) 1996-09-30
US5508279A (en) 1996-04-16
KR950703961A (ko) 1995-11-17
HU9501286D0 (en) 1995-06-28
WO1994009785A2 (en) 1994-05-11
JPH08502977A (ja) 1996-04-02
WO1994009785A3 (en) 1994-08-04
RU2139053C1 (ru) 1999-10-10
HU219482B (hu) 2001-04-28
CA2147866A1 (en) 1994-05-11
NO951718L (no) 1995-05-03
EP0667775A1 (en) 1995-08-23
NZ257993A (en) 1997-05-26
AU5546194A (en) 1994-05-24
NO308196B1 (no) 2000-08-14

Similar Documents

Publication Publication Date Title
IL101243A0 (en) Pharmaceutical compositions for treatment of benign prostatic hyperplasia
NO994778D0 (no) FremgangsmÕter og sammensetninger for behandling av tarmbetennelse
NO971015L (no) Forbindelser og metoder for behandling av cancer
NO914315D0 (no) Fremgangsmaate og sammensetning for surgjoering av underjordiske formasjoner
NO941462D0 (no) Metoder og sammensetninger for profylaktisk og/eller terapeutisk behandling av organhypofunksjon
IL101574A0 (en) Combination pharmaceutical compositions for the treatment of benign prostatic hyperplasia
NO993396L (no) Kinolin- og kinolinforbindelser nyttige i terapi, spesielt i behandlingen av benign prostatisk hyperplasi
DE69300270D1 (de) Strahlungshärtbare Zusammensetzungen und Verwendungsmethode.
DK0925069T3 (da) Anvendelse af Cetrorelix til behandling af godartet prostatahypertrofi og prostatacancer
NO965563D0 (no) Behandling og profylakse av osteoporese
NO951718D0 (no) Fremgangsmåter og sammensetninger av (+)doksazosin for behandling av godartet hyperplasi og aterosklerose
NO971900D0 (no) Blandinger og behandling av multippel sklerose
FI920424A (fi) Foerfarande foer anvaendning av metalliseringsanlaeggning och anordning foer utfoerande av foerfarandet
NO983512D0 (no) Midler for behandling og forhindring av AIDS
EP0855910A4 (en) CONJUGATES USEFUL FOR TREATING BENIN PROSTATIC ADENOMA
NO994631D0 (no) Fremgangsmaater og sammensetninger for behandling av eggstokkreft
NO961226L (no) Blandinger for forebyggelse og behandling av viralinduserte tumorer
DE69306335D1 (de) Prevention und Behandlung von Atherosclerosis
NO20001758D0 (no) Fremgangsmåter og blandinger for behandling av leddgikt
NO912091D0 (no) Fremgangsmaate for inhibering av avleiringer og avleiringsinhiberende sammensetning.
ITMI910219A1 (it) Procedimento per il trattamento di terra da fonderia e/o per anime
KR950700746A (ko) 양성 전립선 비대를 치료하는 조성물 및 방법(Compositions and Methods For Treating Benign Prostatic Hypertrophy)
NO980811D0 (no) Blanding av estere og anvendelse derav
NO952568D0 (no) Behandling av cellulosemateriale og blandinger for anvendelse for dette
AU9128998A (en) Composition and method for the treatment of benign prostatic hyperplasia and prostatitis

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees

Free format text: LAPSED IN MAY 2003